Volume | 3,618,039 |
|
|||||
News | - | ||||||
Day High | 0.24 | Low High |
|||||
Day Low | 0.1775 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.1829 | 0.1775 | 0.24 | 0.1789 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
594 | 3,618,039 | $ 0.20759 | $ 751,067 | - | 0.1275 - 0.418 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:11:22 | 5,000 | $ 0.20 | USD |
CytoDyn Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
195.91M | 921.12M | 556.02M | 0 | -79.82M | -0.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CytoDyn (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.145 | 0.24 | 0.142 | 0.169579 | 868,775 | 0.055 | 37.93% |
1 Month | 0.1505 | 0.24 | 0.1285 | 0.1510964 | 870,776 | 0.0495 | 32.89% |
3 Months | 0.1648 | 0.28 | 0.1275 | 0.1837569 | 1,974,218 | 0.0352 | 21.36% |
6 Months | 0.18 | 0.418 | 0.1275 | 0.1947697 | 2,650,975 | 0.02 | 11.11% |
1 Year | 0.265 | 0.418 | 0.1275 | 0.2019879 | 1,983,562 | -0.065 | -24.53% |
3 Years | 2.82 | 2.83 | 0.1275 | 0.6437176 | 2,172,198 | -2.62 | -92.91% |
5 Years | 0.41995 | 10.01 | 0.1275 | 2.16 | 2,877,032 | -0.21995 | -52.38% |
CytoDyn (QB) Description
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |